[1]
|
Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Har, M., Annane, D. and Bauer, M. (2016) The Third Interna-tional Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810.
https://doi.org/10.1001/jama.2016.0287
|
[2]
|
Sato, R. and Nasu, M. (2015) A Review of Sepsis-Induced Cardio-myopathy. Journal of Intensive Care, 3, Article No. 48. https://doi.org/10.1186/s40560-015-0112-5
|
[3]
|
Lin, H., Wang, W., Lee, M., Meng, Q. and Ren, H. (2020) Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress. Frontiers in Pharmacology, 11, Article No. 210. https://doi.org/10.3389/fphar.2020.00210
|
[4]
|
苏梅, 陈涛, 秦引林, 马瑞. 诺新康注射液对脓毒血症大鼠心肌损伤的保护作用[J]. 中国临床药理学与治疗学, 2015, 20(12): 1328-1334.
|
[5]
|
Liu, Z., Cui, L., Wang, Y. and Guo, Y. (2006) Cardiac Troponin I and Ventricular Arrhythmia in Patients with Chronic Heart Failure. European Journal of Clinical Investigation, 36, 466-472.
https://doi.org/10.1111/j.1365-2362.2006.01655.x
|
[6]
|
Samad, M. and Malempati, S. (2023) Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions. Yale Journal of Biology and Medicine, 96, 137-149.
https://doi.org/10.59249/NCST6937
|
[7]
|
Yaluri, N., Stančáková Yaluri, A., Žeňuch, P., Žeňuchová, Z., Tóth, Š. and Kalanin, P. (2023) Cardiac Biomarkers and Their Role in Identifying Increased Risk of Cardiovascular Complications in COVID-19 Patients. Diagnostics (Basel), 13, Article No. 2508. https://doi.org/10.3390/diagnostics13152508
|
[8]
|
Vallabhajosyula, S., Wang, Z., Murad, M.H., Vallabhajosyula, S., Sundaragiri, P.R. and Kashani, K. (2020) Natriuretic Peptides to Predict Short-Term Mortality in Patients with Sepsis: A Systematic Review and Meta-Analysis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 4, 50-64. https://doi.org/10.1016/j.mayocpiqo.2019.10.008
|
[9]
|
陈宇, 张西京. 早期诊断脓毒症心肌病的心肌标志物[J]. 中华重症医学电子杂志(网络版), 2020, 6(2): 146-150.
|
[10]
|
Ion, A., Stafie, C., Mitu, O., Ciobanu, C.E., Halitchi, D.I. and Costache, A.D. (2021) Biomarkers Utility: At the Borderline between Cardiology and Neurology. Journal of Cardi-ovascular Development and Disease, 8, Article No. 139.
https://doi.org/10.3390/jcdd8110139
|
[11]
|
李娟珍, 王莹. 脓毒症心肌抑制的临床诊断[J]. 中国小儿急救医学, 2016, 23(8): 556-560.
|
[12]
|
Boncler, M., Wu, Y. and Watala, C. (2019) The Multiple Faces of C-Reactive Pro-tein-Physiological and Pathophysiological Implications in Cardiovascular Disease. Molecules, 24, Article No. 2062.
https://doi.org/10.3390/molecules24112062
|
[13]
|
Nuntnarumit, P., Pinkaew, O. and Kitiwanwanich, S. (2002) Pre-dictive Values of Serial C-Reactive Protein in Neonatal Sepsis. Journal of the Medical Association of Thailand, 85, S1151-S1158.
|
[14]
|
Ridker, P. (2003) Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention. Circulation, 107, 363-369. https://doi.org/10.1161/01.CIR.0000053730.47739.3C
|
[15]
|
Balk, R. (2014) Systemic Inflammatory Response Syndrome (SIRS): Where Did It Come from and Is It Still Relevant Today? Virulence, 5, 20-26. https://doi.org/10.4161/viru.27135
|
[16]
|
Afari, M. and Bhat, T. (2016) Neutrophil to Lympho-cyte Ratio (NLR) and Cardiovascular Diseases: An Update. Expert Review of Cardiovascular Therapy, 14, 573-577. https://doi.org/10.1586/14779072.2016.1154788
|
[17]
|
Bartel, D.J. (2009) MicroRNAs: Target Recognition and Regulatory Functions. Cell, 136, 215-233.
https://doi.org/10.1016/j.cell.2009.01.002
|
[18]
|
Zhang, Z.C., Dai, H.W., Yu, Y.H., Yang, J.D. and Hu, C.B. (2012) Usefulness of Heart-Type Fatty Acid-Binding Protein in Patients with Severe Sepsis. Journal of Critical Care, 27, 415e13-8. https://doi.org/10.1016/j.jcrc.2012.01.004
|
[19]
|
Azzazy, H.M., Pelsers, M.M. and Christenson, R.H. (2006) Unbound Free Fatty Acids and Heart-Type Fatty Acid-Binding Protein: Diagnostic Assays and Clinical Applica-tions. Clinical Chemistry, 52, 19-29.
https://doi.org/10.1373/clinchem.2005.056143
|
[20]
|
王婵, 董道然, 荆程桥, 张倩楠, 史晓娟, 宗媛. 心型脂肪酸结合蛋白对脓毒性心肌病的早期诊断价值[J]. 中国急救医学, 2023, 43(3): 169-174.
|
[21]
|
Deng, C., Zhao, L., Yang, Z., Shang, J.J., Wang, C.Y. and Shen, M.Z. (2022) Targeting HMGB1 for the Treatment of Sepsis and Sep-sis-Induced Organ Injury. Acta Pharmacologica Sinica, 43, 520-528.
https://doi.org/10.1038/s41401-021-00676-7
|
[22]
|
Yang, K., Cao, F., Wang, W., Tian, Z. and Yang, L. (2023) The Relationship between HMGB1 and Autophagy in the Pathogenesis of Diabetes and Its Complications. Frontiers in En-docrinology (Lausanne), 14, Article ID: 1141516.
https://doi.org/10.3389/fendo.2023.1141516
|
[23]
|
颜培夏, 王媛媛. HMGB1、cTnI、CK-MB及NT-proBNP对脓毒症心肌损伤的诊断价值[J]. 重庆医学, 2023, 52(5): 737-741.
|
[24]
|
Schenk, M., Bouchon, A., Seibold, F. and Mueller, C. (2007) TREM-1—Expressing Intestinal Macrophages Crucially Amplify Chronic Inflammation in Experi-mental Colitis and Inflammatory Bowel Diseases. Journal of Clinical Investigation, 117, 3097-3106. https://doi.org/10.1172/JCI30602
|
[25]
|
Wu, Y., Wang, F., Fan, X., Bao, R., Bo, L. and Li, J. (2012) Accuracy of Plasma sTREM-1 for Sepsis Diagnosis in Systemic Inflammatory Patients: A Systematic Review and Meta-Analysis. Critical Care, 16, R229.
https://doi.org/10.1186/cc11884
|
[26]
|
Chang, W., Peng, F., Meng, S., Xu, J. and Yang, Y. (2020) Diagnostic Value of Serum Soluble Triggering Expressed Receptor on Myeloid Cells 1 (sTREM-1) in Suspected Sepsis: A Meta-Analysis. BMC Immunology, 21, Article No. 2.
https://doi.org/10.1186/s12865-020-0332-x
|
[27]
|
Dilireba, T., Yang, C., Wang, Y., Ding, Q. and Yu, X. (2022) Research Advance of the Mechanism and Treatment of Septic Cardiomyopathy. Chinese Journal of Critical Care Medi-cine, 34, 1112-1115.
|
[28]
|
王超, 姜阳, 杨欣. 超声心动图联合Tei指数对脓毒症预后评估价值及对心肌损伤的诊断价值研究[J]. 中国医学创新, 2023, 20(6): 116-120.
|
[29]
|
陈文冲, 李德平, 罗建立, 周亚锋, 郑明江, 黎洁芳. 心肌损伤标志物和序贯器官衰竭评估评分评估感染性休克患者预后的价值分析[J]. 广西医学, 2021, 43(2): 167-169, 196.
|